Trial Outcomes & Findings for SMART Trial: Intrapersonal and Interpersonal Stigma Reduction (NCT NCT04693416)
NCT ID: NCT04693416
Last Updated: 2023-03-09
Results Overview
Change in Enacted Stigma subscore from Substance Use Stigma Mechanisms Scale (SU-SMS) pre- and post-intervention. All responses are given on a 5-point Likert-type scale, with higher scores indicating greater endorsement of substance use stigma. Enacted (6 items) scale can be created by taking the average of the item responses given. Minimum score = 6, Maximum score = 30. Reported mean is the change in these scores (pre score - post score), so a positive number for the mean is a reduction in stigma using average scores from the Enacted Stigma subscore.
COMPLETED
PHASE2
71 participants
Immediately before and 2-weeks post-intervention delivery
2023-03-09
Participant Flow
Participants in the intrapersonal intervention were recruited from community centers in the target area. Participants in the interpersonal intervention were support persons referred by the participants in the intrapersonal intervention.
Participant milestones
| Measure |
Intrapersonal Stigma Reduction
The intervention will include education about substance use disorders (diagnosis, prognosis, and treatment), goal setting to assist the individual in preparing for change, and decisional balance to assist the individual in measuring the costs and benefits about disclosure of mental health problems and exercises to practice how to disclose. Facilitation of an intake assessment for treatment will be offered (with assistance in making the appointment, getting transportation and childcare, and securing a pro-bono status at a outpatient treatment facility).
Intrapersonal Stigma Reduction: Brief intervention for stigma reduction
|
Interpersonal Stigma Reduction
The intervention for family members and support persons of enrolled intrapersonal participants will include education about substance use disorders (diagnosis, prognosis, and treatment), stigma reduction, and how to provide support for someone with substance use disorder.
Interpersonal Stigma Reduction: Brief intervention for support persons of intrapersonal intervention participants.
|
|---|---|---|
|
Overall Study
STARTED
|
50
|
21
|
|
Overall Study
COMPLETED
|
37
|
21
|
|
Overall Study
NOT COMPLETED
|
13
|
0
|
Reasons for withdrawal
| Measure |
Intrapersonal Stigma Reduction
The intervention will include education about substance use disorders (diagnosis, prognosis, and treatment), goal setting to assist the individual in preparing for change, and decisional balance to assist the individual in measuring the costs and benefits about disclosure of mental health problems and exercises to practice how to disclose. Facilitation of an intake assessment for treatment will be offered (with assistance in making the appointment, getting transportation and childcare, and securing a pro-bono status at a outpatient treatment facility).
Intrapersonal Stigma Reduction: Brief intervention for stigma reduction
|
Interpersonal Stigma Reduction
The intervention for family members and support persons of enrolled intrapersonal participants will include education about substance use disorders (diagnosis, prognosis, and treatment), stigma reduction, and how to provide support for someone with substance use disorder.
Interpersonal Stigma Reduction: Brief intervention for support persons of intrapersonal intervention participants.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
13
|
0
|
Baseline Characteristics
SMART Trial: Intrapersonal and Interpersonal Stigma Reduction
Baseline characteristics by cohort
| Measure |
Intrapersonal Stigma Reduction
n=50 Participants
The intervention will include education about substance use disorders (diagnosis, prognosis, and treatment), goal setting to assist the individual in preparing for change, and decisional balance to assist the individual in measuring the costs and benefits about disclosure of mental health problems and exercises to practice how to disclose. Facilitation of an intake assessment for treatment will be offered (with assistance in making the appointment, getting transportation and childcare, and securing a pro-bono status at a outpatient treatment facility).
Intrapersonal Stigma Reduction: Brief intervention for stigma reduction
|
Interpersonal Stigma Reduction
n=21 Participants
The intervention for family members and support persons of enrolled intrapersonal participants will include education about substance use disorders (diagnosis, prognosis, and treatment), stigma reduction, and how to provide support for someone with substance use disorder.
Interpersonal Stigma Reduction: Brief intervention for support persons of intrapersonal intervention participants.
|
Total
n=71 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
42.9 years
n=5 Participants
|
36.3 years
n=7 Participants
|
41.0 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
25 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
40 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
25 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
31 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
50 Participants
n=5 Participants
|
21 Participants
n=7 Participants
|
71 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
50 Participants
n=5 Participants
|
21 Participants
n=7 Participants
|
71 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
50 participants
n=5 Participants
|
21 participants
n=7 Participants
|
71 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Immediately before and 2-weeks post-intervention deliveryPopulation: Intrapersonal arm only
Change in Enacted Stigma subscore from Substance Use Stigma Mechanisms Scale (SU-SMS) pre- and post-intervention. All responses are given on a 5-point Likert-type scale, with higher scores indicating greater endorsement of substance use stigma. Enacted (6 items) scale can be created by taking the average of the item responses given. Minimum score = 6, Maximum score = 30. Reported mean is the change in these scores (pre score - post score), so a positive number for the mean is a reduction in stigma using average scores from the Enacted Stigma subscore.
Outcome measures
| Measure |
Intrapersonal Stigma Reduction
n=37 Participants
The intervention will include education about substance use disorders (diagnosis, prognosis, and treatment), goal setting to assist the individual in preparing for change, and decisional balance to assist the individual in measuring the costs and benefits about disclosure of mental health problems and exercises to practice how to disclose. Facilitation of an intake assessment for treatment will be offered (with assistance in making the appointment, getting transportation and childcare, and securing a pro-bono status at a outpatient treatment facility).
Intrapersonal Stigma Reduction: Brief intervention for stigma reduction
|
|---|---|
|
Enacted Stigma (Intrapersonal)
|
0.730 score on a scale
Standard Deviation 3.813
|
PRIMARY outcome
Timeframe: Immediately before and 2-weeks post-intervention deliveryChange in Anticipated Stigma subscore from Substance Use Stigma Mechanisms Scale (SU-SMS) pre- and post-intervention. All responses are given on a 5-point Likert-type scale, with higher scores indicating greater endorsement of substance use stigma. Enacted (6 items) scale can be created by taking the average of the item responses given. Minimum score = 6, Maximum score = 30. Reported mean is the change in these scores (pre score - post score), so a positive number for the mean is a reduction in stigma using average scores from the Anticipated Stigma subscore.
Outcome measures
| Measure |
Intrapersonal Stigma Reduction
n=37 Participants
The intervention will include education about substance use disorders (diagnosis, prognosis, and treatment), goal setting to assist the individual in preparing for change, and decisional balance to assist the individual in measuring the costs and benefits about disclosure of mental health problems and exercises to practice how to disclose. Facilitation of an intake assessment for treatment will be offered (with assistance in making the appointment, getting transportation and childcare, and securing a pro-bono status at a outpatient treatment facility).
Intrapersonal Stigma Reduction: Brief intervention for stigma reduction
|
|---|---|
|
Anticipated Stigma (Intrapersonal)
|
0.514 score on a scale
Standard Deviation 4.985
|
PRIMARY outcome
Timeframe: Immediately before and 2-weeks post-intervention deliveryChange in Internalized Stigma subscore from Substance Use Stigma Mechanisms Scale (SU-SMS) pre- and post-intervention. All responses are given on a 5-point Likert-type scale, with higher scores indicating greater endorsement of substance use stigma. Enacted (6 items) scale can be created by taking the average of the item responses given. Minimum score = 6, Maximum score = 30. Reported mean is the change in these scores (pre score - post score), so a positive number for the mean is a reduction in stigma using average scores from the Internalized Stigma subscore.
Outcome measures
| Measure |
Intrapersonal Stigma Reduction
n=37 Participants
The intervention will include education about substance use disorders (diagnosis, prognosis, and treatment), goal setting to assist the individual in preparing for change, and decisional balance to assist the individual in measuring the costs and benefits about disclosure of mental health problems and exercises to practice how to disclose. Facilitation of an intake assessment for treatment will be offered (with assistance in making the appointment, getting transportation and childcare, and securing a pro-bono status at a outpatient treatment facility).
Intrapersonal Stigma Reduction: Brief intervention for stigma reduction
|
|---|---|
|
Internalized Stigma (Intrapersonal)
|
2.324 score on a scale
Standard Deviation 4.720
|
PRIMARY outcome
Timeframe: Pre/post intervention (week 0)Population: Interpersonal arm only
Exposure to drug users index includes questions regarding if a participant has been exposed to a drug user at home, at work, at school, etc. (7 items; No = 0, Yes = 1). Score is total count (min score = 0, max score = 7). Higher scores indicate more exposure to drug users. Reported mean is the change in this score pre and post intervention (post score - pre score).
Outcome measures
| Measure |
Intrapersonal Stigma Reduction
n=21 Participants
The intervention will include education about substance use disorders (diagnosis, prognosis, and treatment), goal setting to assist the individual in preparing for change, and decisional balance to assist the individual in measuring the costs and benefits about disclosure of mental health problems and exercises to practice how to disclose. Facilitation of an intake assessment for treatment will be offered (with assistance in making the appointment, getting transportation and childcare, and securing a pro-bono status at a outpatient treatment facility).
Intrapersonal Stigma Reduction: Brief intervention for stigma reduction
|
|---|---|
|
Exposure to Drug Users Index Score
|
-0.476 score on a scale
Standard Deviation 1.601
|
PRIMARY outcome
Timeframe: Pre/post intervention (week 0: post-test immediately followed intervention)Population: This measure was only given to the Interpersonal arm only.
The Drug Use Stigmatization Scale measures stigma against drug users. The scale contains 7 items scored on a 5-point likert scale with higher scores representing higher stigma. The score is the average score of the seven items. Min score = 1, Max score = 5. Reported mean is the change in these scores (pre score - post score), so a positive number for the mean is a reduction in stigma.
Outcome measures
| Measure |
Intrapersonal Stigma Reduction
n=21 Participants
The intervention will include education about substance use disorders (diagnosis, prognosis, and treatment), goal setting to assist the individual in preparing for change, and decisional balance to assist the individual in measuring the costs and benefits about disclosure of mental health problems and exercises to practice how to disclose. Facilitation of an intake assessment for treatment will be offered (with assistance in making the appointment, getting transportation and childcare, and securing a pro-bono status at a outpatient treatment facility).
Intrapersonal Stigma Reduction: Brief intervention for stigma reduction
|
|---|---|
|
Drug Use Stigmatization Scale Score
|
2.105 score on a scale
Standard Deviation 4.345
|
PRIMARY outcome
Timeframe: Pre/post intervention (week 0: post-test immediately followed intervention)Population: This measure was only given to the Interpersonal arm only.
The Stigma of Drug Users Scale measures stigma. There are 10 items scored on a 5-point likert scale. Higher scores indicate higher stigma. The score is the average of the 10 items (Min score = 1, Max score = 5). The reported mean for this outcome measure is the change in this score pre and post intervention (pre score - post score). A positive mean indicates a reduction in stigma.
Outcome measures
| Measure |
Intrapersonal Stigma Reduction
n=21 Participants
The intervention will include education about substance use disorders (diagnosis, prognosis, and treatment), goal setting to assist the individual in preparing for change, and decisional balance to assist the individual in measuring the costs and benefits about disclosure of mental health problems and exercises to practice how to disclose. Facilitation of an intake assessment for treatment will be offered (with assistance in making the appointment, getting transportation and childcare, and securing a pro-bono status at a outpatient treatment facility).
Intrapersonal Stigma Reduction: Brief intervention for stigma reduction
|
|---|---|
|
Stigma of Drug Users Scale Score
|
1.211 score on a scale
Standard Deviation 2.323
|
SECONDARY outcome
Timeframe: 2-weeks post-interventionNumber of participants in intrapersonal arm who made an appointment for treatment after receiving the intervention.
Outcome measures
| Measure |
Intrapersonal Stigma Reduction
n=37 Participants
The intervention will include education about substance use disorders (diagnosis, prognosis, and treatment), goal setting to assist the individual in preparing for change, and decisional balance to assist the individual in measuring the costs and benefits about disclosure of mental health problems and exercises to practice how to disclose. Facilitation of an intake assessment for treatment will be offered (with assistance in making the appointment, getting transportation and childcare, and securing a pro-bono status at a outpatient treatment facility).
Intrapersonal Stigma Reduction: Brief intervention for stigma reduction
|
|---|---|
|
Engagement in Treatment
|
4 Participants
|
Adverse Events
Intrapersonal Stigma Reduction
Interpersonal Stigma Reduction
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Karen Derefinko, PhD
University of Tennessee Health Science Center
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place